Credit Suisse’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-82,108
| Closed | -$2.35M | – | 4235 |
|
|
2018
Q4 | $2.35M | Sell |
82,108
-110,792
| -57% | -$3.15M | ﹤0.01% | 2107 |
|
|
2018
Q3 | $5.38M | Sell |
192,900
-31,649
| -14% | -$890K | ﹤0.01% | 1649 |
|
|
2018
Q2 | $6.26M | Buy |
224,549
+24,069
| +12% | +$645K | 0.01% | 1575 |
|
|
2018
Q1 | $4.98M | Buy |
200,480
+34,496
| +21% | +$839K | ﹤0.01% | 1715 |
|
|
2017
Q4 | $4.02M | Buy |
165,984
+56,640
| +52% | +$1.49M | ﹤0.01% | 1921 |
|
|
2017
Q3 | $3.02M | Buy |
109,344
+10,148
| +10% | +$271K | ﹤0.01% | 2197 |
|
|
2017
Q2 | $2.49M | Buy |
99,196
+56,872
| +134% | +$1.41M | ﹤0.01% | 2092 |
|
|
2017
Q1 | $1.14M | Sell |
42,324
-18,270
| -30% | -$505K | ﹤0.01% | 2773 |
|
|
2016
Q4 | $1.59M | Sell |
60,594
-5,828
| -9% | -$144K | ﹤0.01% | 2624 |
|
|
2016
Q3 | $1.66M | Sell |
66,422
-11,781
| -15% | -$275K | ﹤0.01% | 2521 |
|
|
2016
Q2 | $1.7M | Sell |
78,203
-12
| -0% | -$214 | ﹤0.01% | 2455 |
|
|
2016
Q1 | $1.17M | Buy |
78,215
+37,765
| +93% | +$633K | ﹤0.01% | 2600 |
|
|
2015
Q4 | $886K | Sell |
40,450
-47,528
| -54% | -$886K | ﹤0.01% | 2917 |
|
|
2015
Q3 | $1.39M | Sell |
87,978
-73,698
| -46% | -$1.18M | ﹤0.01% | 2533 |
|
|
2015
Q2 | $2.31M | Buy |
161,676
+85,829
| +113% | +$1.45M | ﹤0.01% | 2444 |
|
|
2015
Q1 | $1.31M | Sell |
75,847
-5,586
| -7% | -$98.7K | ﹤0.01% | 2755 |
|
|
2014
Q4 | $1.46M | Buy |
81,433
+10,084
| +14% | +$162K | ﹤0.01% | 2820 |
|
|
2014
Q3 | $937K | Buy |
71,349
+790
| +1% | +$10.6K | ﹤0.01% | 3116 |
|
|
2014
Q2 | $1.01M | Sell |
70,559
-30,273
| -30% | -$395K | ﹤0.01% | 3273 |
|
|
2014
Q1 | $1.28M | Sell |
100,832
-625,187
| -86% | -$8.16M | ﹤0.01% | 2892 |
|
|
2013
Q4 | $7.26M | Sell |
726,019
-468,860
| -39% | -$5.32M | 0.01% | 1514 |
|
|
2013
Q3 | $15.7M | Buy |
1,194,879
+70,857
| +6% | +$929K | 0.02% | 880 |
|
|
2013
Q2 | $16.1M | Buy |
+1,124,022
| New | +$14.1M | 0.02% | 866 |
|
Other funds holding NXTM
Credit Suisse's NXTM Position: Q1 2019 in Review
Credit Suisse sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 82,108 shares — an estimated $2.35M sold.
Credit Suisse first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $16.1M in Q2 2013. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Credit Suisse reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Credit Suisse sold 82,108 NxStage Medical Inc. shares in Q1 2019, an estimated $2.35M.
- Credit Suisse first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- Credit Suisse's NxStage Medical Inc. position peaked at $16.1M in Q2 2013.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Credit Suisse's 13F filing for Q1 2019, filed 14 May 2019.